Topical Retinoid — Acne / Photoaging
Pregnancy: CONTRAINDICATED — teratogenic; effective contraception required; all topical retinoids contraindicated in pregnancy
Tretinoin (Topical)
Brand names: Retin-A, Retrieve, Acnecide (different ingredient)
Adult dose
Dose: 0.025–0.1% cream or gel — start low (0.025%), apply a pea-sized amount
Route: Topical
Frequency: Once nightly (every other night initially to build tolerance)
Max: 0.1% once nightly
Used for acne vulgaris (mild-moderate — combined with topical antibiotic or benzoyl peroxide) and photoaging (off-label in UK — licensed for acne). Start at lowest strength, apply to entire face after washing, increase concentration gradually. Sun protection mandatory.
Paediatric dose
Dose: Apply pea-sized amount to face nightly topical/kg
Route: Topical
Frequency: Once nightly (every other night initially)
Max: 0.05% for acne in adolescents
BNFc: licensed from 12 years for acne. Start with 0.025% to minimise retinoid dermatitis.
Dose adjustments
Renal
No dose adjustment required (topical — negligible systemic absorption)
Hepatic
No dose adjustment required
Paediatric weight-based calculator
BNFc: licensed from 12 years for acne. Start with 0.025% to minimise retinoid dermatitis.
Clinical pearls
- CONTRAINDICATED in pregnancy — teratogenic (topical retinoids absorbed systemically; pregnancy test and contraception required in women of childbearing potential on systemic therapy; topical tretinoin systemic absorption is low but contraindication maintained)
- Initial flare: acne worsens weeks 1–4 (purging effect — comedone expulsion); warn patients not to stop treatment during this phase
- Apply at night: photolabile — UV light degrades tretinoin; morning sun protection (SPF 30+) mandatory
- Adapalene (0.1%) is generally better tolerated in sensitive skin — less irritating than tretinoin 0.025%; good alternative for acne
- Benzoyl peroxide interaction: apply benzoyl peroxide in the morning, tretinoin at night — benzoyl peroxide oxidises tretinoin if applied simultaneously, reducing efficacy
- Photoaging (UK off-label): strongest evidence for any topical product in reducing fine lines and photodamage (Kligman studies)
Contraindications
- Pregnancy — CONTRAINDICATED (teratogenic — all topical retinoids)
- Breastfeeding
- Eczema or rosacea (can exacerbate)
- Broken or sunburned skin
Side effects
- Retinoid dermatitis (erythema, peeling, dryness — most common; resolves with continued use)
- Photosensitivity
- Initial acne flare (weeks 1–4)
- Hyperpigmentation or hypopigmentation (post-inflammatory)
- Skin thinning (long-term high concentration)
Interactions
- Other topical retinoids — additive irritation
- Keratolytics (salicylic acid) — additive irritation; avoid concurrent use
- Benzoyl peroxide — inactivates tretinoin if applied simultaneously; use AM/PM split
Monitoring
- Skin tolerability (retinoid dermatitis)
- Acne response at 8–12 weeks
- Sun protection compliance
Reference: BNFc; BNF 90; BNFc; BAD Acne Guidelines 2020; Kligman et al. (1986) Retin-A photoaging; NICE NG198 (Acne). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD